Conferences & Events

Found 113,108 articles

• Innate Pharma to Participate in Upcoming June 2023 Investor Conferences

  5/23/2023

  Innate Pharma SA announced that members of its senior management team are scheduled to participate in the following upcoming conferences.

• Carmot Therapeutics to Present Clinical Data from its Pipeline of Treatments for Obesity and Diabetes at the 83rd American Diabetes Association Scientific Sessions

  5/23/2023

  Carmot Therapeutics, Inc., a clinical-stage biotechnology company developing disease-modifying therapies for metabolic diseases, announced multiple presentations to take place at the American Diabetes Association Annual Meeting from June 23–26, 2023 in San Diego, CA.

• ImmunityBio to Participate in the Jefferies Global Healthcare Conference - May 22, 2023

  5/22/2023

  ImmunityBio, Inc., a clinical-stage immunotherapy company, announced that Executive Chairman and Global Chief Scientific and Medical Officer Dr. Patrick Soon-Shiong, M.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 7, 2023, at 10:00 am Eastern Time at the Marriott Marquis, New York.

• Scribe Therapeutics to Participate in Upcoming Investor Conferences in May and June 2023

  5/22/2023

  Scribe Therapeutics Inc., a genetic medicines company unlocking the potential of CRISPR to transform human health, announced that the Company will participate in the following upcoming investor conferences in May and June.

• Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala

  5/22/2023

  Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, was honored by the CARES Foundation, Inc. for its ongoing development of tildacerfont for patients with classic congenital adrenal hyperplasia.

• City of Hope presents new research on cancer immunotherapies at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

  5/22/2023

  City of Hope announced that one of its researchers will present results from a SWOG Cancer Research Network Phase 3 study comparing nivolumab and brentuximab vedotin in patients with advanced stage classic Hodgkin lymphoma at an ASCO press briefing.

• DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Conference

  5/22/2023

  DNA Script announced the broad commercial availability of the fully automated SYNTAX™ DNA printing platform, which consists of the benchtop STX-200 system, latest biochemistry advancements, robust reagent kits, and intuitive software enhancements.

• Dana Farber Cancer Institute’s Jimmy Fund Celebrates 75 years of Progress and Impact on May 22

  5/22/2023

  Dana-Farber Cancer Institute’s Jimmy Fund will launch its 75th anniversary on Monday, May 22. Activities will include adult and pediatric patients unveiling and previewing the Jimmy Fund inspired cow, “Strong as Iron,” from this summer’s CowParade New England presented by Herb Chambers art installation.

• Lumos Pharma to Participate in World Orphan Drug Congress USA

  5/22/2023

  Lumos Pharma, Inc., a biopharmaceutical company advancing an oral therapeutic candidate for idiopathic Pediatric Growth Hormone Deficiency through Phase 2 clinical trials, announced that management will participate in panel discussions at the World Orphan Drug Congress USA 2023, held in Washington, D.C., May 23-25, 2023.

• Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)

  5/22/2023

  Immunovia AB published the notice to the Annual General Meeting 2023 on 25 April 2023 together with the Nomination Committee's motivated statement which included the Nomination Committee's proposals for board members.

• Novanta to Present at Baird's 2023 Global Consumer, Technology & Services Conference on Wednesday, June 7, 2023

  5/22/2023

  Novanta Inc. announced that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at Baird's 2023 Global Consumer, Technology & Services Conference on Wednesday, June 7, 2023, in New York, NY.

• NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich

  5/22/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich.

• Karuna Therapeutics to Present Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the American Society of Clinical Psychopharmacology Annual Meeting

  5/22/2023

  Karuna Therapeutics, Inc. announced that data from the EMERGENT-1, EMERGENT-2, and EMERGENT-3 trials evaluating KarXT in schizophrenia will be presented at the American Society of Clinical Psychopharmacology Annual Meeting being held from May 30, 2023 to June 2, 2023 in Miami, Florida.

• Reviva Pharmaceuticals Announces Presentation of Clinical Pharmacology Studies Data on Brilaroxazine at the ASPET 2023 Annual Meeting

  5/22/2023

  Reviva Pharmaceuticals Holdings, Inc. has presented two posters on promising clinical pharmacology and safety studies data on the novel serotonin-dopamine stabilizer brilaroxazine at the American Society for Pharmacology and Experimental Therapeutics 2023 annual meeting took place in St.

• GenScript to Debut Expanded Synthetic Biology Product Line at SynBioBeta 2023

  5/22/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, is a sponsor of this year's SynBioBeta Conference in Oakland, California.

• Affimed Announces Annual General Meeting of Shareholders - May 22, 2023

  5/22/2023

  Affimed N.V. announced that its 2023 Annual General Meeting of Shareholders will be held on June 21, 2023 at 14:00 CET at the NH Collection Amsterdam Barbizon Palace, Prins Hendrikkade 59-72, 1012 AD Amsterdam, the Netherlands.

• Seelos Therapeutics to Participate in Two Upcoming Healthcare Conferences

  5/22/2023

  Seelos Therapeutics, Inc. today announced that it will participate in two upcoming healthcare conferences.

• MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference

  5/22/2023

  MiNK Therapeutics today announced presentation of clinical data from its allo-iNKTs (agenT-797) in COVID-19 associated Acute Respiratory Distress Syndrome (CARDS) at the American Thoracic Society (ATS) International Conference in Washington D.C.

• Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st, 2023

  5/22/2023

  Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st , 2023.

• Ansa Biotechnologies Announces First Shipments of Complex Clonal DNA Sequences to Customers in its Early Access Program

  5/22/2023

  Ansa Biotechnologies, Inc will present more information regarding these milestones at the SynBioBeta conference on Wednesday, May 24, 2023, at 11:46 a.m. PT.